Elephant vine

Other Names

AavegiAdhogudaAjaantriAjantriArgyreia nervosaArgyreia speciosaAvegiBaby woodroseBichtarak GuguliBidaraBijtadakChagalantrikaChhagalantriConvolvulus nervosusDirghabalukaElephant climberElephant creeperElephant ear vineGhav belGugguliHasthi valliHawaiian baby woodroseIpomoea speciosaJirnadaruJungakaKatar-palaiKotarapushpiLettsomia nervosaMahashyamaMahishavallariMurvaSamandar-sosaSamnudra balliSamudra haleSamudra patraSamudra soshSamudra-shoshSamudrapacchaiSamudrapachaSamudrapalSamudrapelaSamudraphalakaSamudrashoshSamudrashoshaSamudrasoahSamudrasokaSamudravalliSamundar-ka-patSamuttira-p-palaiSilver morning gloryTrikonakandaVallariVardharoVellariVidharaVrddhadaruVriddhadaruVriddhadarukaVruddhadaruVrushyagandhikaWoolly morning gloryYuvika Bidhara

Synopsis

Elephant Vine (Argyreia nervosa Burm. f. Bojer): A Comprehensive Reference

1. Identity and Botanical Classification

Accepted Names and Synonyms

Elephant vine — formally known as Argyreia nervosa — is a large perennial climbing vine belonging to the family Convolvulaceae. Both Argyreia nervosa and Argyreia speciosa are interchangeable botanical names for the same species, referred to in Ayurveda as Vriddhadaru. The full taxonomic authority is Argyreia nervosa (Burm. f.) Bojer, referring to the original description by N. L. Burman (filius) and the subsequent combination by Wenceslas Bojer.

Common names include elephant creeper, woolly morning glory, and Hawaiian baby woodrose. Additional common names include silky elephant glory, woolly morning glory, and — in Hindi — Samandar-ka-pat, Ghav-patta, Vidhara, and Samundarsokha; Sanskrit names include Samundrasosha, Antakotarapushpi, and Vridhadaraka. The name "Hawaiian baby woodrose," though widely used, is a misnomer: despite its colloquial name, Argyreia nervosa is native to Asia, not Hawaii.

Botanical Description and Distribution

Argyreia nervosa stands out thanks to its glossy heart-shaped leaves and purple funnel-shaped flowers. It is a perennial climbing vine native to the Indian subcontinent and introduced to numerous areas worldwide, including Hawaii, Africa, and the Caribbean. Hooker (1885) states that A. nervosa is native to India, from Assam to Belgaum and Mysore, and is common on the Bengal plain. While native to India, it is also cultivated in Central and South America, East Asia, and the Caribbean; within India, it is commonly found in Orissa, Bihar, and Assam, as well as South India.

The two botanical varieties are Argyreia nervosa var. nervosa and Argyreia nervosa var. speciosa, the roots of which are used in Ayurvedic medicine. The plant thrives in tropical and subtropical climates; where temperatures fall below 13 °C (55 °F), it is grown in a warm greenhouse, while elsewhere it is grown on arbors, pergolas, walls, or trees.

Parts Used and Common Preparations

Parts used medicinally include the seeds, leaves, roots, and flowers. In Ayurvedic practice, the roots are the most commonly employed part for tonic and medicinal decoctions, while the seeds have attracted significant modern interest for their ergoline alkaloid content.

Traditional preparations span a wide range. The leaf is slightly heated and applied over wounds associated with pus for quicker healing; the powder of the root is given in a dose of 3–5 g to treat oligospermia; cold infusion or decoction of the plant is given in a dose of 40–50 ml to control diabetes; the decoction of the root is used to treat leucorrhea and fever; the powder of the root is given with honey for cough; and the powder of the seed is given in a dose of 2–3 g to treat insomnia. Modern commercial preparations include seed powders, root powders, capsule-form seed extracts, and leaf extracts used in topical nanoemulgel formulations for wound care.

2. Traditional and Historical Use

Ayurvedic Tradition

Argyreia nervosa is a highly valued medicinal plant in the Ayurvedic system of medicine; in Ayurveda, Vidhara is renowned for its Rasayana (rejuvenating), Balya (strength-promoting), and Vajikarana (aphrodisiac) properties. It is particularly beneficial in managing Vata-related disorders such as paralysis, arthritis, muscular weakness, and neurological ailments.

The plant has been extensively documented in various Ayurvedic Nighantus (classical materia medica texts), including Dhanvantari Nighantu, Madanpala Nighantu, Kaiyadeva Nighantu, Raj Nighantu, Bhavaprakash Nighantu, and Adarsha Nighantu, among others. In Sanskrit, Argyreia speciosa (syn. A. nervosa) is described as an important Rasayana herb used extensively as an adaptogen in the Ayurvedic system; the name "Vridhadaraka" means "anti-aging."

In Ayurveda, uses of C. [Argyreia] are described for various ailments including digestive, eye, and ear diseases, irregular menstruation, and asthma. It has also been used as a tonic, an analgesic, and anthelmintic medicine. The root has historically held a central position: the root is described as bitter, aphrodisiac, diuretic, and used in gonorrhea, rheumatism, and diseases of the nervous system.

Ethnomedicinal Use Outside Ayurveda

Traditionally, its leaves, roots, and seeds are utilized in Ayurveda as a rasayana or rejuvenator and are employed in the treatment of ulcers, wounds, skin infections, and inflammation. In India, leaves and root parts of the plant are used as antiseptic and anti-inflammatory drugs; in the Unani system of medicine, its roots are also recognized.

The leaves of A. speciosa are emollient, vesicant, stimulant, and rubefacient and are traditionally used in the treatment of various skin diseases. The roots are regarded as beneficial in anemia, diabetes, obesity, syphilis, tuberculosis, cerebral disorders, and ulcer wound, and are also used as aphrodisiac, anti-inflammatory, brain tonic, cardiotonic, expectorant, digestive, carminative, and appetizer.

Seeds: Traditional versus Modern Psychoactive Use

LSA-containing seeds have been utilized in small quantities in Ayurvedic herbal medicine; however, the seeds were not widely known to have psychoactive properties until the mid-to-late 20th century and have no tradition of ceremonial use for religious purposes. The seeds contain alkaloids like ergine and lysergic acid derivatives and are used in small doses to relieve insomnia and enhance mental calmness within the traditional Ayurvedic context. The more potent psychoactive use of seeds as a "legal high" is a modern phenomenon that is distinct from classical Ayurvedic application.

3. Key Constituents and Phytochemistry

Ergoline (Indole) Alkaloids

The seeds of Argyreia nervosa are the phytochemically richest part of the plant with respect to psychoactive alkaloids. Chemical analysis showed that the seeds of Argyreia nervosa contain the highest percentage of indole alkaloid constituents (0.5–0.9%) of the genera of the Convolvulaceae thus far studied; a total of 19 indole alkaloids were identified by thin-layer and paper chromatographic procedures. Of these, lysergene, festuclavine, setoclavine, isosetoclavine, agroclavine, elymoclavine, ergine, and isoergine were isolated by column chromatographic procedures and characterized by TLC and IR analyses; penniclavine, chanoclavine-I, chanoclavine-II, ergometrine, ergometrinine, lysergic acid α-hydroxyethylamide, isolysergol, racemic chanoclavine-II, molliclavine, lysergol, and isolysergic acid α-hydroxyethylamide were identified by TLC only.

More recent analytical studies have clarified the dominant alkaloid profile. In two commercial products analyzed, LSA/LSA-isomers were dominant with 83–84% of total ergot alkaloids, followed by ergometrine/ergometrinine at 10–17%; LSA and ergometrine/ergometrinine could thus be confirmed as the main ergot alkaloids present in A. nervosa seeds and products, while other ergot alkaloids were of minor importance. A study reported stereoisomers of ergine to be found in the seeds at a concentration of 0.325% of dry weight.

Importantly, alkaloid content is highly variable. The total ergot alkaloid amounts varied considerably between products by a factor of 8.6, and the LSA concentration ranged from approximately 3 μg (lowest amount in one seed) to approximately 34 μg (highest amount in one capsule preparation), while among raw seeds the LSA concentration varied from approximately 3–15 μg per seed.

Lysergic acid amide (LSA), ergometrine, lysergol/elymoclavine/setoclavine, chanoclavine, lysergic acid, and their respective stereoisomers were identified in commercial products, as well as penniclavine and lysergic acid α-hydroxyethylamide; methylergometrine, methysergide, and lysergylalanine were also detected, along with some high-molecular-weight ergot alkaloid derivatives and hydroxyalanine-derived ergopeptide fragments.

Non-Alkaloid Phytochemicals

According to phytochemical studies, Argyreia nervosa contains a variety of bioactive components contributing to its broad pharmacological profile, including triterpenoids, steroids, lipids, coumarin glycosides, alkaloids (ergine, ergonovine, isoergine), and flavonoids (quercetin, kaempferol, rutin). Leaves of A. nervosa mainly contain β-sitosterol, 1-tricontanol, and quercetin.

Phytochemical investigation of the seeds resulted in the isolation of a new steroidal glycoside, (24R)-ergost-5-en-11-oxo-3β-ol-α-D-glucopyranoside, designated as argyroside. The seeds principally also contain free amino acids, fatty acids, ergometrine, ergoline alkaloids, caffeic acid, and ethyl caffeate. The plant is reported to contain several phytochemical constituents including alkaloids, carbohydrates, tannins, amber-colored resin, sterols, and saponins. Novel coumarin compounds — including 7-hydroxy-6-methoxycoumarin, 6,7-dihydroxycoumarin, furanocoumarin, and scopoletin-7-O-β-glucopyranoside — have also been identified from ethanolic extracts of aerial parts.

4. Mechanisms of Action

Ergoline Alkaloids: Receptor Pharmacology

The primary psychoactive constituent, lysergic acid amide (LSA, ergine), is structurally and pharmacologically related to LSD. Structurally analogous to lysergic acid diethylamide (LSD) but featuring a simple amide group rather than a diethylamide, LSA exhibits partial agonist activity at serotonin 5-HT2A and 5-HT1A receptors, akin to LSD's mechanism; this receptor agonism disrupts default mode network activity in the brain, promoting altered perception, synesthesia, and introspective states characteristic of serotonergic psychedelics. Binding assays indicate LSA's affinity for 5-HT2A receptors (pKi > 7), positioning it as a key mediator of hallucinogenic effects, though with lower potency than LSD due to reduced lipophilicity and slower receptor kinetics. Similarly to ergot alkaloids generally, ergine is assumed to also bind to D2-dopamine receptors.

The psychoactive alkaloids isoergine and ergine are mainly found in the plant seeds and show psychoactive effects quite similar to lysergic acid diethylamide (LSD), but not as intensive.

Non-Psychoactive Mechanisms

Argyreia nervosa is an important source of compounds like tricontanol, β-sitosterol, and p-hydroxyinnamoyloctadecanolate, which are reported to be useful as aphrodisiac, immunomodulatory, hepatoprotective, hypoglycemic, anti-inflammatory, anticonvulsant, and nootropic agents. At doses of 100 and 200 mg/kg, aqueous root extract enhanced memory and effectively reversed memory loss brought on by scopolamine and diazepam, while significant nootropic action correlated with improved acetylcholinesterase activity in the brain. This suggests a cholinergic mechanism for the plant's reported cognitive effects.

The bioactive compounds — alkaloids, flavonoids, saponins, tannins, terpenoids, and glycosides — are responsible for a broad spectrum of pharmacological activities, including antimicrobial, anti-inflammatory, antioxidant, wound healing, hepatoprotective, and immunomodulatory effects. The flavonoid quercetin, identified in leaves, is a known inhibitor of cyclooxygenase enzymes and free-radical scavenger that is likely to contribute to the observed anti-inflammatory and antioxidant activities.

5. Scientific Evidence by Area of Use

5.1 Nootropic and Cognitive Effects

Evidence level: Preclinical only (animal models); no human clinical trials identified.

Ayurveda frequently uses the plant to treat neurological issues; several studies have demonstrated that A. nervosa has nootropic and memory-enhancing properties; at doses of 100 and 200 mg/kg, aqueous root extract enhanced memory and effectively reversed memory loss brought on by scopolamine and diazepam, while significant nootropic action correlated with improved acetylcholinesterase activity in the brain. A further study referenced in the literature (Joshi et al., 2007, Journal of Health Science, 53[4]:382–388) evaluated the nootropic effect of Argyreia speciosa in mice. All current data are from animal experiments; no controlled human clinical trials on cognitive enhancement have been reported.

5.2 Aphrodisiac and Reproductive Effects

Evidence level: Preclinical only (animal models); no peer-reviewed human clinical trials identified.

Alcoholic extract of roots showed aphrodisiac activity in male rats as evidenced from stimulated mounting behavior in a dose-dependent manner. The aphrodisiac property of Argyreia nervosa has been noted to have promising potential to be developed into an effective medicine for stimulating male sexual activity.

A study investigating diabetic-induced reproductive impairment (Convolvulaceae, animal model) found that diabetic rats treated with a higher dose of A. nervosa extract (ANH) showed decreased fasting blood glucose (0.52-fold), abnormal sperm morphology (0.50-fold), and sperm DNA fragmentation index (0.74-fold), along with improved semen quality; ANH also increased testicular testosterone (1.40-fold), FSH (1.91-fold), LH (1.69-fold), and mRNA expression of steroidogenic enzymes StAR, 17β-HSD, and 3β-HSD. These findings are from rodent models only.

5.3 Anti-inflammatory and Analgesic Effects

Evidence level: Preclinical (in vitro and animal models); no human trials identified.

Multiple experimental studies have evaluated the anti-inflammatory activity of leaf extracts in rodent models, including carrageenan-induced paw edema assays. Numerous pharmacological actions — including antipyretic, wound healing, antioxidant, anti-inflammatory, and analgesic effects — have been demonstrated in experimental research. Referenced studies include Srivastava et al. (1972), who reported antiinflammatory activity of roots of Argyreia nervosa (Mediscope, 15:219–22), and more recent work by George et al. (2016) in the World Journal of Pharmaceutical Research evaluating anti-inflammatory and analgesic activity of leaf extracts. All evidence remains at the preclinical stage.